Skip to content

D27.505.954.427.700.122

12 trials

Sponsors

Clinica Dr. Norton Sayeg Ltda. EPP, Escola Paulista de Medicina, Universidade Federal da Bahia, Fundação Oswaldo Cruz, Centro De Psiquiatria E Pesquisas Sandra Ruschel Ltda

Conditions

Mood DisordersNephropatyNeuritisPost traumatic stress disorderPost-traumatic stress stateSevere depressive episode with psychotic symptomsTreatment-resistant Depressionobsessive-compulsive disorder

Phase 3

A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Avoiding in Adult Participants With Treatment-resistant Depression
RecruitingRBR-3dccf6
Clinica Dr. Norton Sayeg Ltda. EPPTreatment-resistant Depression
Start: 2015-07-09Updated: 2025-10-27
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants with Treatment-resistant Depression
RecruitingRBR-3xk32h
Clinica Dr. Norton Sayeg Ltda. EPPTreatment-resistant Depression
Start: 2015-08-24Updated: 2025-10-27
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment resistant Depression
RecruitingRBR-5vkxts
Centro De Psiquiatria E Pesquisas Sandra Ruschel LtdaTreatment-resistant Depression
Start: 2015-07-23Updated: 2025-10-27
A study of Intranasal Rapid Action Esketamine for Major Depression Treatment Resistant
RecruitingRBR-9pgk4f
Centro De Psiquiatria E Pesquisas Sandra Ruschel LtdaTreatment-resistant Depression
Start: 2015-08-10Updated: 2025-10-27
Sertraline Use on prevention of intradialytic low blood pressure
Active, not recruitingRBR-8xkj95
Universidade do Sul de Santa CatarinaNephropaty
Start: 2016-12-01Updated: 2025-10-27
Randomized trial using amitriptyline medication to prevent neuropathic pain in patients who have leprosy neuritis.
Active, not recruitingRBR-5539cm
Fundação Oswaldo CruzNeuritis
Start: 2020-03-30Updated: 2025-10-27
Phase II, randomized, double-blind, crossover, placebo-controlled clinical trial to evaluate the efficacy and safety of Esketamine as an adjunct to standard care in patients with Obsessive-Compulsive Disorder- OCD
RecruitingRBR-6kmdtgb
Hospital Universitário Professor Edgard Santosobsessive-compulsive disorder
Start: 2022-03-01Updated: 2025-10-27
Clinical trial to evaluate the use of the medication Esketamine with intravenous administration in association with the treatment of patients with severe depression who present with hallucinations and delusions
RecruitingRBR-4n5f5jb
Universidade Federal da BahiaSevere depressive episode with psychotic symptoms
Start: 2023-04-01Updated: 2025-10-27
Randomized, crossover, placebo-controlled clinical trial to evaluate the effect and safety of sketamine in aiding the improvement of standard care for Post Traumatic Stress Disorder
RecruitingRBR-44msqcs
Universidade Federal da BahiaPost-traumatic stress state
Start: 2021-09-30Updated: 2025-10-27
Effect of Ketamine combined with conventional treatment in Treatment-Resistant Depression and Suicide Risk
Active, not recruitingRBR-99z7jnq
Hospital Universitário Walter Cantídio Universidade Federal do CearáMood Disorders
Start: 2025-02-15Updated: 2025-10-27

Unknown Phase

Related Papers